RFA: CCTS Core Services Voucher
CCTS Core Services Voucher Support
UPDATE: As of January 1, 2017, the NIH requires all investigators seeking NIH funding for clinical research to have completed Good Clinical Practice (GCP) training. This includes the CCTS voucher support program. View the NIH Notice | Get more information from OSU ORRP | Complete your GCP training here
Beginning May 1, 2016, the CCTS will offer a Core Services Voucher Support program.
The OSU CCTS facilitates and supports translation of scientific discoveries into innovations that improve health. To achieve this mission and advance translational research, the CCTS is awarding vouchers to provide funding support to investigators who require assistance from an Ohio State University or Nationwide Children’s Hospital core service to enable preliminary work and generate data for new or ongoing projects and/or to secure fee-based core services for expert consultation services (such as biostatistics) with the ultimate goal of furthering clinical and translational research.
These awards are intended to be used on projects that are ready for services immediately (“just in time” data). The CCTS will award OSU and NCH investigators vouchers worth up to $4,000 (see eligibility 4 through 6 in the RFA) in core services (eligible cores listed in the RFA) per investigator and per project. | Download the RFA
Please email firstname.lastname@example.org if you have any questions about the process.
Pharmacogenomics and Next Generation Sequencing
Pharmacogenomic and molecular genetic analysis, and next generation DNA and RNA sequencing are provided to CCTS investigators by the Pharmacogenomics Core Laboratory in the OSU College of Medicine Center for Pharmacogenomics.
The Pharmacogenomics Core Laboratory offers Next Generation Sequencing of genes, human exomes, small genomes, RNA transcripts, targeted AmpliSeqTM human transcriptomes and whole transcriptomes, including ribosomally depleted transcriptomes that assess all RNA transcript isoforms and non-coding RNA’s (including non-polyadenylated transcripts). We are a Certified Service Provider of Ion Torrent Exome and Transcriptome Sequencing, as performed on our Ion Torrent Proton and PGM Next Generation Sequencers.
The Pharmacogenomics Core Lab has considerable expertise performing AmpliSeqTM whole human transcriptome analysis on low input or difficult samples such as FFPE and other less than optimum cell and tissue sources. This is in addition to our expertise in molecular techniques such as genotyping, allelic measurements of RNA and DNA, and CRISPR technologies.
The faculty and staff in the Center for Pharmacogenomics have developed new approaches for the discovery of genetic variants, with a focus on gene regulation and gene/gene interactions, incorporating innovative genome-scale technologies such as massively-parallel sequencing, network analysis, and data integration from large, publically available datasets.
We are pleased to consult on development of experiments or broader approaches that further the research and translational goals of the CCTS. We are participants in the Core Services Voucher Program as well as providing independent fee for service or collaborative research services.
OSU College of Medicine
Center for Pharmacogenomics
|Eligibility Criteria||Important Dates|
||Application Deadline 03/01/2017 Anticipated Start Date 04/01/2017|